Adaptive Biotechnologies Corp. (ADPT)
29.04
-0.44
(-1.49%)
USD |
NASDAQ |
Nov 13, 16:00
29.04
0.00 (0.00%)
After-Hours: 19:59
Adaptive Biotechnologies Market Cap : 4.692B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 4.763B |
| November 11, 2026 | 4.837B |
| November 10, 2026 | 4.744B |
| November 09, 2026 | 4.889B |
| November 06, 2026 | 4.521B |
| November 05, 2026 | 4.335B |
| November 04, 2026 | 4.315B |
| November 03, 2026 | 4.168B |
| November 02, 2026 | 4.049B |
| October 30, 2026 | 4.237B |
| October 29, 2026 | 4.481B |
| October 28, 2026 | 4.513B |
| October 27, 2026 | 4.400B |
| October 26, 2026 | 4.178B |
| October 23, 2026 | 4.058B |
| October 22, 2026 | 3.883B |
| October 21, 2026 | 4.029B |
| October 20, 2026 | 3.884B |
| October 19, 2026 | 3.809B |
| October 16, 2026 | 3.821B |
| October 15, 2026 | 4.069B |
| October 14, 2026 | 4.075B |
| October 13, 2026 | 4.021B |
| October 12, 2026 | 4.067B |
| October 09, 2026 | 4.213B |
| Date | Value |
|---|---|
| October 08, 2026 | 4.150B |
| October 07, 2026 | 4.180B |
| October 06, 2026 | 4.279B |
| October 05, 2026 | 4.746B |
| October 02, 2026 | 4.509B |
| October 01, 2026 | 4.353B |
| September 30, 2026 | 4.597B |
| September 29, 2026 | 4.576B |
| September 28, 2026 | 4.535B |
| September 25, 2026 | 4.681B |
| September 24, 2026 | 4.703B |
| September 23, 2026 | 4.436B |
| September 22, 2026 | 4.463B |
| September 21, 2026 | 4.431B |
| September 18, 2026 | 4.551B |
| September 17, 2026 | 4.541B |
| September 16, 2026 | 4.401B |
| September 15, 2026 | 4.244B |
| September 14, 2026 | 3.941B |
| September 11, 2026 | 3.849B |
| September 10, 2026 | 3.854B |
| September 09, 2026 | 3.884B |
| September 08, 2026 | 3.872B |
| September 04, 2026 | 3.862B |
| September 03, 2026 | 3.908B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Champions Oncology, Inc. | 65.14M |
| Medpace Holdings, Inc. | 18.23B |
| Avantor, Inc. | 10.52B |
| Personalis, Inc. | 1.702B |
| 10X Genomics, Inc. | 7.650B |
Market Cap Related Metrics
| PS Ratio | 15.97 |
| Price to Book Value | 26.63 |
| Price | 29.04 |
| Earnings Yield | -1.55% |